The Michigan GI Society (MIGI) would like to thank all attendees of the 2022 Michigan GI Society Inaugural Conference, held July 15-17, 2022, at the Grand Traverse Resort and Spa in Traverse City, MI!

​

The Michigan Gastrointestinal Society is a professional organization providing education, support and advocacy for healthcare providers in Michigan. Connecting gastroenterology providers including clinicians, researchers, advanced practice providers and allied health professionals.

​

The Michigan Gastrointestinal Society was founded in 2020 by Dr. Jami Kinnucan and Dr. Richard Saad as a statewide membership organization available to gastroenterologists, certified registered nurse practitioners, physician assistants, nurses and allied health professionals engaged in the practice of gastroenterology, hepatology and endoscopy.

The mission of the society is to facilitate sharing of information among colleagues, foster support and collegiality, and state and national level advocacy for healthcare issues in the area of gastroenterology, hepatology and endoscopy facing providers in Michigan.

​

Sincerely,​

The Michigan GI Society Conference Steering Committee

Laith Jamil, MD, FASGE, FACG, AGAF

Jami Kinnucan, MD, FACG

Richard Saad, MD, MS, FACG

Fadi Antaki, MD

Marc Piper, MD

Mehwish Ahmed, MD

Syed Mohammed Jafri, MD

Sam Gunn, MD

Alex Weick, MD

Eva Alsheik, MD

Brian Ginnebaugh, MD

Ahmad Abu-Heija, MD

Amar Hassan, MD

Kristen Cares, MD

Kevin Sroufe

​

To learn more about the Michigan GI Society Conference Steering Committee Click here.

​

​

​

Target Audience

This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).

 

Statement of Need 

The goal of this program is to provide important clinical and scientific data on the management of GI disorders and CLD.

 

Learning Objectives

Upon completion of this symposium, participants should be better able to:

• Describe current guidelines for the diagnosis and management of CLD and GI disorders

• Employ an evidence-based approach to the management of CLD and GI disorders

• Identify new advances presented at 2022 DDW and assess their potential impact on clinical practice

 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Cincinnati and the Michigan Gastrointestinal Society (MIGI). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

​

The University of Cincinnati designates this live activity for a maximum of 8.75 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

MOC Designation

Successful completion of this CME activity enables the participant to earn up to 8.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

 

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

 

All additional planning committee members, the University of Cincinnati staff and the Michigan Gastrointestinal Society (MIGI) staff have no relationships to disclose.

 

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

 

Disclaimer Statement

The opinions expressed during the live activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati. The information is presented for the purpose of advancing the attendees’ professional development.

​

​

​

This activity is jointly provided by the University of Cincinnati and the

Michigan Gastrointestinal Society (MIGI).

​

Supported by educational grants from Mallinckrodt Pharmaceuticals, 

Janssen Biotech, Inc., Phathom Pharmaceuticals, Inc., and Salix Pharmaceuticals